CD74 & CD22
Loading...Anti-CD74 & CD22 Products
+ Filter
Loading...-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
- Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) (TAB-183-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fv - disulfide stabilized
- Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG4, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1716CL-S(P)) (TAB-1716CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1717CL-S(P)) (TAB-1717CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1718CL-S(P)) (TAB-1718CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1719CL-S(P)) (TAB-1719CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1720CL-S(P)) (TAB-1720CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1721CL-S(P)) (TAB-1721CL-S(P))
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1722CL-S(P)) (TAB-1722CL-S(P))
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1715CL-S(P)) (TAB-1715CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG1, κ
- Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1724CL-S(P)) (TAB-1724CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib
- Human Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1725CL-S(P)) (TAB-1725CL-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: Block, Cyt, ELISA, FuncS
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2) (TAB-0196CL-F(E))
-
- Application: ELISA, In vivo
-
- Derivation: Human
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2-Cys) (TAB-0197CL-F(E))
-
- Application: ELISA, In vivo
-
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: IF, FC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: FC, IF, IHC, IP, FuncS
- Human Anti-CD74 Recombinant Antibody (TAB-139CL) (TAB-139CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1715CL-F(E)) (TAB-1715CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1716CL-F(E)) (TAB-1716CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1717CL-F(E)) (TAB-1717CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1718CL-F(E)) (TAB-1718CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1719CL-F(E)) (TAB-1719CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1729CL-S(P)) (TAB-1729CL-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: IF, FC
- Human Anti-CD74 Recombinant Antibody; scFv Fragment (TAB-0569CL-S(P)) (TAB-0569CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, FC
- Human Anti-CD74 Recombinant Antibody; scFv Fragment (TAB-0570CL-S(P)) (TAB-0570CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, FC
- Human Anti-CD74 Recombinant Antibody; scFv Fragment (TAB-0571CL-S(P)) (TAB-0571CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, FC
- Human Anti-CD74 Recombinant Antibody; scFv Fragment (TAB-0572CL-S(P)) (TAB-0572CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, FC
- Human Anti-CD74 Recombinant Antibody; scFv Fragment (TAB-0573CL-S(P)) (TAB-0573CL-S(P))
-
- Derivation: Phage display library
- Species Reactivity: Cynomolgus monkey
- Type: Human scFv
- Application: ELISA
- Human Anti-CD74 Recombinant Antibody; scFv Fragment (TAB-0574CL-S(P)) (TAB-0574CL-S(P))
-
- Derivation: Phage display library
- Species Reactivity: Cynomolgus monkey
- Type: Human scFv
- Application: ELISA
- Rat Anti-CD22 Recombinant Antibody (clone 2D6) (NEUT-315CQ)
-
- Species Reactivity: Mouse
- Type: Rat IgG1, κ
- Application: Block
-
- Class: Class II
- Antigen: CD74
- Antigen Species: Human
- Peptide: KPVSKMRMATPLLMQAL
- Conjugate: PE
-
- Class: Class II
- Antigen: CD74
- Antigen Species: Human
- Peptide: KPVSKMRMATPLLMQAL
- Conjugate: PE
-
- Class: Class II
- Antigen: CD74
- Antigen Species: Human
- Peptide: KPVSKMRMATPLLMQAL
- Conjugate: PE
-
- Class: Class II
- Antigen: CD74
- Antigen Species: Human
- Peptide: LPKPPKPVSKMRMATPLLMQALPM
- Conjugate: PE
-
- Class: Class II
- Antigen: CD74
- Antigen Species: Human
- Peptide: LPKPPKPVSKMRMATPLLMQALPM
- Conjugate: PE
-
- Class: Class II
- Antigen: CD74
- Antigen Species: Human
- Peptide: LPKPPKPVSKMRMATPLLMQALPM
- Conjugate: PE
-
- Class: Class II
- Antigen: CD74
- Antigen Species: Human
- Peptide: LPKPPKPVSKMRMATPLLMQALPM
- Conjugate: PE
- Human Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-001LC-F(E)) (TAB-001LC-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric antibody (mouse/human)
- Application: ELISA
- Anti-Human CD22 Recombinant Antibody Fab Fragment (VM1000) (TAB-002LC-F(E))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: ELISA, SPR
- Human Anti-CD74 Recombinant Antibody; Fab Fragment (TAB-0569CL-F(E)) (TAB-0569CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, FC
- Human Anti-CD74 Recombinant Antibody; Fab Fragment (TAB-0570CL-F(E)) (TAB-0570CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, FC
- Human Anti-CD74 Recombinant Antibody; Fab Fragment (TAB-0571CL-F(E)) (TAB-0571CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, FC
- Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2) (TAB-0196CL-S(P))
-
- Application: ELISA, In vivo
- Mouse Anti-CD22 Recombinant Antibody (clone 5LB129) (MOB-0349MZ)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA
- Anti-Human CD22 Recombinant Antibody scFv Fragment (RFB4) (TAB-1728CL-S(P))
-
- Application: IF, FC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab' - G2a - kappa
- Application: ELISA, FC, IP, FuncS, IF, Neut, WB
- Recombinant Anti-Human CD22 Antibody Fab Fragment (MOB-1248z-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab
- Application: IP, RIA, FuncS
- Recombinant Anti-Human CD22 Antibody scFv Fragment (MOB-1248z-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: ELISA, WB, IF, FuncS
- anti-CD22 immunotoxin RFB4 (scFv)-PE (AGTO-L048E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD22 immunotoxin RFB4 (scFv)-DT (AGTO-L048D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD22 immunotoxin RFB4 (scFv)-Gel (AGTO-L048G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-Human CD74 VHH Single Domain Antibody (TAB-0011CL-VHH) (TAB-0011CL-VHH)
-
- Species Reactivity: Cross-react with mouse CD74
- Type: VHH
- Application: ELISA, FC, Internalization, Inhib, FuncS
- Anti-CD22 immunotoxin RFB4 (IgG)-RTA (AGTO-G077R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD22 immunotoxin RFB4 (IgG)-Gel (AGTO-G077G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD22 immunotoxin RFB4 (IgG)-PE (AGTO-G077E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD22 immunotoxin RFB4 (IgG)-DT (AGTO-G077D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD22 immunotoxin RFB4 (IgG)-Sap (AGTO-G077S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Recombinant Anti-Human CD74 VHH Single Domain Antibody (NAB-466-VHH)
-
- Species Reactivity: Human
- Type: Llama VHH
- Application: FUNC, FA, IP, ChiP
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1714CL-S(P)) (TAB-1714CL-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, WB
- anti-CD22 immunotoxin RFB4 (scFv)-RTA (AGTO-L048R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD22 immunotoxin RFB4 (scFv)-Sap (AGTO-L048S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1723CL-S(P)) (TAB-1723CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib
- Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1714CL-F(E)) (TAB-1714CL-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, WB
- Anti-CD74 (clone 006 (A))-vc-MMAE ADC (ADC-061CL)
-
- Target: CD74
- Linker: VC (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD74 (clone 005 (A))-vc-MMAE ADC (ADC-062CL)
-
- Target: CD74
- Linker: VC (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone hu10F4)-MCC-DM1 ADC (ADC-027LZY)
-
- Target: CD22
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD22-mc-vc-PABc-MMAE ADC (ADC-033LZY)
-
- Target: CD22
- Linker: mc-VC-PABc(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD22-mc-vc-PABc-NMS249 ADC (ADC-097LZY)
-
- Target: CD22
- Linker: mc-VC-PABc (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: NMS249
- Anti-CD22-AcBut-CalichDMH ADC (ADC-006LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
- Anti-CD22 (clone HB22.7)-saporin ADC (ADC-154LZY)
-
- Target: CD22
- Drug: saporin
- Anti-CD22 (clone G5/44)-AcBut-CalichDMH ADC (ADC-003LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
-
- Target: CD22
- Linker: acetyl butyrate linker
- Drug: calicheamicin
- Anti-CD22 (CR011)-vc-MMAE ADC (RG7593) (ADC-L028)
-
- Target: CD22
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
-
- Host Species: Mouse
- Specificity: Human
- Type: Mouse antibody
- Classification: Fab glycosylation
- Glycosylation site: FR1 of VK
- Anti-CD22 (clone 10F4v3)-BMPEO-DM1 ADC (ADC-211CL)
-
- Target: CD22
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-212CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-213CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone 5E8)-SMCC-DM1 ADC (ADC-214CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 7A2)-SMCC-DM1 ADC (ADC-215CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v1)-SMCC-DM1 ADC (ADC-216CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v2)-SMCC-DM1 ADC (ADC-217CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (RFB4)-mcc-DM1 ADC (ADC-028LCT)
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (10F4)-AcBut-Calicheamicin ADC (ADC-029LCT)
-
- Target: CD22
- Linker: AcBut
- Drug: Calicheamicin
- Anti-CD74 (clone 011 (B))-vc-MMAE ADC (ADC-060CL)
-
- Target: CD74
- Linker: VC (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22-CL2A-SN-38 ADC (ADC-030LCT)
-
- Target: CD22
- Linker: CL2A
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD22-CL2E-SN-38 ADC (ADC-031LCT)
-
- Target: CD22
- Linker: CL2E
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD22-MC-MMAF ADC (ADC-032LCT)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22-MCC-DM1 ADC (ADC-033LCT)
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v2)-MC-MMAF ADC (ADC-218CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (clone 10F4v3)-SMCC-DM1 ADC (ADC-219CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-220CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (clone 10F4v3)-SPP-DM1 ADC (ADC-221CL)
-
- Target: CD22
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-222CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone 10F4)-SMCC-DM1 ADC (ADC-223CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone RFB4)-SMCC-DM1 ADC (ADC-224CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone RFB4)-MC-vc-PAB-MMAF ADC (ADC-225CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD74 (HuMax-CD74)-MC-vc-PAB-MMAF ADC (ADC-085LCT)
-
- Target: CD74
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAF (Monomethyl auristatin F)
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Predicted to enable CD4 receptor binding activity; protein phosphatase binding activity; and sialic acid binding activity. Involved in B cell activation; negative regulation of B cell receptor signaling pathway; and regulation of endocytosis. Located in early endosome and recycling endosome.
CD74 (CD74 Molecule) is a Protein Coding gene. Diseases associated with CD74 include Undifferentiated Pleomorphic Sarcoma and Mantle Cell Lymphoma. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and Innate Immune System. Gene Ontology (GO) annotations related to this gene include identical protein binding and amyloid-beta binding.

